Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362708513> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W4362708513 endingPage "91" @default.
- W4362708513 startingPage "85" @default.
- W4362708513 abstract "The National Center for Global Health and Medicine plays a central role in the treatment and research of infectious diseases in Japan. It has conducted various research and development activities on drugs to treat coronavirus disease 2019 (COVID-19) with clinical questions as starting points. Clinical trials are essential in developing new treatment modalities, but we have noticed some characteristic difficulties in clinical trials on emerging and re-emerging infectious diseases. For example, since there is no standard of care when an emerging infectious disease starts to spread, establishing an appropriate control group is complicated, and many things are hurried at the start of trials. This means there is little time to arrange a placebo, and conducting blinded, randomized, controlled trials has been difficult. Another issue characteristic of infectious disease has been that progress in enrolling subjects is affected by the spread of the disease. It was also a struggle to select institutions that provide medical care on the front lines of infectious disease and conduct clinical trials regularly. To start multicenter clinical trials expeditiously, a regulated and structured network is thus considered necessary. From the perspective of implementation, it is preferable to conduct decentralized clinical trials (DCTs) that do not depend on people coming to the medical institution, while from the perspective of preventing infections during the spread of COVID-19, wide adoption of eConsent is desirable. Based on the experience of COVID-19, new measures must be taken to prepare for emerging and re-emerging infectious diseases in the future." @default.
- W4362708513 created "2023-04-09" @default.
- W4362708513 creator A5017738732 @default.
- W4362708513 creator A5030396783 @default.
- W4362708513 creator A5032031868 @default.
- W4362708513 creator A5087259617 @default.
- W4362708513 date "2023-04-30" @default.
- W4362708513 modified "2023-09-23" @default.
- W4362708513 title "Clinical trial experience in Japan and future issues in developing drugs to treat COVID-19" @default.
- W4362708513 cites W2043952513 @default.
- W4362708513 cites W2093286248 @default.
- W4362708513 cites W3027630905 @default.
- W4362708513 cites W3040751560 @default.
- W4362708513 cites W3089272419 @default.
- W4362708513 cites W3093956495 @default.
- W4362708513 cites W3113196149 @default.
- W4362708513 cites W3128236342 @default.
- W4362708513 cites W3172701548 @default.
- W4362708513 cites W4206413684 @default.
- W4362708513 cites W4210334206 @default.
- W4362708513 cites W4213448046 @default.
- W4362708513 cites W4225701835 @default.
- W4362708513 cites W4281393347 @default.
- W4362708513 cites W4281723624 @default.
- W4362708513 cites W4283647070 @default.
- W4362708513 cites W4283744107 @default.
- W4362708513 cites W4294096286 @default.
- W4362708513 cites W4307433189 @default.
- W4362708513 cites W4311504655 @default.
- W4362708513 cites W4321372105 @default.
- W4362708513 doi "https://doi.org/10.35772/ghm.2023.01022" @default.
- W4362708513 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37128222" @default.
- W4362708513 hasPublicationYear "2023" @default.
- W4362708513 type Work @default.
- W4362708513 citedByCount "0" @default.
- W4362708513 crossrefType "journal-article" @default.
- W4362708513 hasAuthorship W4362708513A5017738732 @default.
- W4362708513 hasAuthorship W4362708513A5030396783 @default.
- W4362708513 hasAuthorship W4362708513A5032031868 @default.
- W4362708513 hasAuthorship W4362708513A5087259617 @default.
- W4362708513 hasBestOaLocation W43627085131 @default.
- W4362708513 hasConcept C142724271 @default.
- W4362708513 hasConcept C144024400 @default.
- W4362708513 hasConcept C177713679 @default.
- W4362708513 hasConcept C2779134260 @default.
- W4362708513 hasConcept C2779903281 @default.
- W4362708513 hasConcept C2779973787 @default.
- W4362708513 hasConcept C3008058167 @default.
- W4362708513 hasConcept C36289849 @default.
- W4362708513 hasConcept C502991105 @default.
- W4362708513 hasConcept C524204448 @default.
- W4362708513 hasConcept C535046627 @default.
- W4362708513 hasConcept C71924100 @default.
- W4362708513 hasConceptScore W4362708513C142724271 @default.
- W4362708513 hasConceptScore W4362708513C144024400 @default.
- W4362708513 hasConceptScore W4362708513C177713679 @default.
- W4362708513 hasConceptScore W4362708513C2779134260 @default.
- W4362708513 hasConceptScore W4362708513C2779903281 @default.
- W4362708513 hasConceptScore W4362708513C2779973787 @default.
- W4362708513 hasConceptScore W4362708513C3008058167 @default.
- W4362708513 hasConceptScore W4362708513C36289849 @default.
- W4362708513 hasConceptScore W4362708513C502991105 @default.
- W4362708513 hasConceptScore W4362708513C524204448 @default.
- W4362708513 hasConceptScore W4362708513C535046627 @default.
- W4362708513 hasConceptScore W4362708513C71924100 @default.
- W4362708513 hasIssue "2" @default.
- W4362708513 hasLocation W43627085131 @default.
- W4362708513 hasLocation W43627085132 @default.
- W4362708513 hasLocation W43627085133 @default.
- W4362708513 hasOpenAccess W4362708513 @default.
- W4362708513 hasPrimaryLocation W43627085131 @default.
- W4362708513 hasRelatedWork W1501007924 @default.
- W4362708513 hasRelatedWork W1993780631 @default.
- W4362708513 hasRelatedWork W2129267808 @default.
- W4362708513 hasRelatedWork W2160479322 @default.
- W4362708513 hasRelatedWork W2319635624 @default.
- W4362708513 hasRelatedWork W2440758576 @default.
- W4362708513 hasRelatedWork W3132770720 @default.
- W4362708513 hasRelatedWork W4283788080 @default.
- W4362708513 hasRelatedWork W4323351292 @default.
- W4362708513 hasRelatedWork W4362708513 @default.
- W4362708513 hasVolume "5" @default.
- W4362708513 isParatext "false" @default.
- W4362708513 isRetracted "false" @default.
- W4362708513 workType "article" @default.